Gilead Sciences Inc
NASDAQ:GILD
Gilead Sciences Inc
Other Liabilities
Gilead Sciences Inc
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Liabilities
$3.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
24%
|
|
Abbvie Inc
NYSE:ABBV
|
Other Liabilities
$32.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Liabilities
$6.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
0%
|
|
Moderna Inc
NASDAQ:MRNA
|
Other Liabilities
$957m
|
CAGR 3-Years
51%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Liabilities
$1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
51%
|
CAGR 10-Years
33%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Liabilities
$1.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
See Also
What is Gilead Sciences Inc's Other Liabilities?
Other Liabilities
3.4B
USD
Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Other Liabilities amounts to 3.4B USD.
What is Gilead Sciences Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
24%
Over the last year, the Other Liabilities growth was -33%. The average annual Other Liabilities growth rates for Gilead Sciences Inc have been -20% over the past three years , -14% over the past five years , and 24% over the past ten years .